AGA and cancer: Thus, hJAA-F11 antibodies, the humanized versions of the murine monoclonal IgG3 antibody mJAA-F11 [4–12], hold promise towards targeting TF-Ag-α expressing cancers for therapeutic and diagnostic applications.